Publications

Department of Medicine faculty members published more than 3,600 peer-reviewed articles in 2024.

Annals of the rheumatic diseases

POS1115 EFFECT OF SECUKINUMAB VERSUS ADALIMUMAB BIOSIMILAR ON RADIOGRAPHIC PROGRESSION IN PATIENTS WITH RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: SUBGROUP ANALYSES BY BASELINE SYNDESMOPHYTES AND C-REACTIVE PROTEIN STATUS.

2023

Authors: X. Baraliakos, D. Van der Heijde, P. Machado, V. Navarro-Compán, L. S. Gensler, P. Pertel, E. Quebe-Fehling, A. Readie, H. Richards, D. Poddubnyy

Annals of the rheumatic diseases

POS1103 BIMEKIZUMAB MAINTAINED IMPROVEMENTS IN EFFICACY ENDPOINTS AND HAD A CONSISTENT SAFETY PROFILE THROUGH 52 WEEKS IN PATIENTS WITH NON-RADIOGRAPHIC AND RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: RESULTS FROM TWO PARALLEL PHASE 3 STUDIES.

2023

Authors: X. Baraliakos, A. Deodhar, D. Van der Heijde, M. Magrey, W. P. Maksymowych, T. Tomita, H. Xu, M. Oortgiesen, U. Massow, C. Fleurinck, A. Ellis, T. Vaux, J. Smith, A. Marten, L. S. Gensler

Annals of the rheumatic diseases

POS0683 AN EXPLORATORY ANALYSIS OF THE POTENTIAL DISCONNECT BETWEEN OBJECTIVE INFLAMMATORY RESPONSE AND CLINICAL RESPONSE FOLLOWING CERTOLIZUMAB PEGOL TREATMENT IN PATIENTS WITH ACTIVE AXIAL SPONDYLOARTHRITIS.

2023

Authors: M. Rudwaleit, F. Van den Bosch, H. Marzo-Ortega, V. Navarro-Compán, R. Tham, T. Kumke, L. Bauer, M. Kim, L. S. Gensler

Annals of the rheumatic diseases

POS0668 LOW UVEITIS RATES IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS TREATED WITH BIMEKIZUMAB: POOLED RESULTS FROM PHASE 2B/3 TRIALS.

2023

Authors: M. Rudwaleit, M. Brown, F. A. Van Gaalen, N. Haroon, L. S. Gensler, C. Fleurinck, A. Marten, U. Massow, N. De Peyrecave, T. Vaux, K. White, A. Deodhar, I. Van der Horst-Bruinsma

Annals of the rheumatic diseases

OP0059 EFFECT OF SECUKINUMAB VERSUS ADALIMUMAB BIOSIMILAR ON RADIOGRAPHIC PROGRESSION IN PATIENTS WITH RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: A RANDOMISED PHASE IIIB STUDY.

2023

Authors: X. Baraliakos, M. Østergaard, D. Poddubnyy, D. Van der Heijde, A. Deodhar, P. Machado, V. Navarro-Compán, K. G. Hermann, M. Kishimoto, E. Y. Lee, L. S. Gensler, U. Kiltz, M. Eigenmann, P. Pertel, A. Readie, H. Richards, B. Porter, J. Braun

Annals of the rheumatic diseases

OP0055 ASAS CONSENSUS DEFINITION OF EARLY AXIAL SPONDYLOARTHRITIS.

2023

Authors: V. Navarro-Compán, D. Benavent, D. Capelusnik, D. Van der Heijde, R. B. M. Landewé, D. Poddubnyy, A. Van Tubergen, X. Baraliakos, F. Van den Bosch, F. A. Van Gaalen, L. S. Gensler, C. López-Medina, H. Marzo-Ortega, A. Moltó, R. Perez Alamino, M. Rudwaleit, M. G. H. Van de Sande, R. Sengupta, U. Weber, S. Ramiro

Annals of the rheumatic diseases

AB0938 SAFETY PROFILE OF BIMEKIZUMAB AT WEEK 16 IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS AND PSORIATIC ARTHRITIS: RESULTS FROM FOUR PLACEBO-CONTROLLED PHASE 3 STUDIES.

2023

Authors: D. Poddubnyy, L. S. Gensler, P. J. Mease, A. M. Orbai, R. B. Warren, B. Ink, U. Massow, D. Assudani, C. Fleurinck, V. Shende, J. Smith, L. Peterson, K. White, R. B. M. Landewé

Annals of the rheumatic diseases

AB0937 TOFACITINIB EFFICACY AND SAFETY IN PATIENTS WITH ANKYLOSING SPONDYLITIS BY BASELINE C-REACTIVE PROTEIN LEVELS: A POST HOC ANALYSIS.

2023

Authors: A. Deodhar, X. Baraliakos, M. Magrey, L. S. Gensler, A. V. Thorat, C. Kinch, S. Pemmaraju, M. J. Cadatal, P. Nash

Annals of the rheumatic diseases

POS0823 UPTAKE OF INFLIXIMAB BIOSIMILARS AMONG U.S. RHEUMATOLOGY PRACTICES THROUGH 2022.

2023

Authors: J. Yazdany, J. LI, E. Roberts, R. Stovall, G. Schmajuk

Annals of the rheumatic diseases

POS0665 INCIDENCE RATE AND FACTORS ASSOCIATED WITH FRACTURES AMONG ADULTS WITH ANKYLOSING SPONDYLITIS IN THE UNITED STATES.

2023

Authors: R. Stovall, E. Kersey, J. LI, R. Baker, C. Anastasiou, A. Palmowski, G. Schmajuk, L. S. Gensler, J. Yazdany